In Brief This Week:, Bio-Techne, DermTech, Cue Health, DiaSorin, Devyser, More
News items for the week of Feb. 27, 2023.
Applied BioCode, Hardy Diagnostics Ink US Distribution Agreement for MDx System, Test Menu
Hardy Diagnostics will begin offering Applied BioCode's MDx-3000 molecular diagnostic system, tests, and analyte specific reagents to US hospitals and reference laboratories.
Applied BioCode Multiplex SARS-CoV-2/Flu/RSV Test Nabs EUA From FDA
The company previously received Emergency Use Authorization for its SARS-CoV-2 test and for pooling samples with that test.
FDA Authorizes Pooled Sampling With Applied BioCode Coronavirus Test
The assay was first authorized in June for the detection of the SARS-CoV-2 N gene in upper respiratory specimens and bronchoalveolar lavage.
FDA Allows Emergency Use of Applied BioCode, Kaiser Permanente, Emory University Coronavirus Tests
Applied BioCode's test may be performed by any CLIA-certified lab, while Kaiser Permanente's and Emory's must be run at their developers' labs.